Showing results (201-210 of 1,352) with videos related to

Sort By:
Pageof 136
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 24, 2013
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stentsThomas Pilgrim, Bindu Kalesan, Thomas Zanchin, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Heart (British Cardiac Society)|August 29, 2014
Long-term outcome of elderly patients with severe aortic stenosis as a function of treatment modalityThomas Pilgrim, Lars Englberger, Martina Rothenbühler, et al.
European Heart Journal. Cardiovascular Imaging|August 14, 2019
Does isolated mitral annular calcification in the absence of mitral valve disease affect clinical outcomes after transcatheter aortic valve replacement?Taishi Okuno, Masahiko Asami, Faisal Khan, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 19, 2024
Incidence and predictors of continued ascending aortic dilatation after TAVI in patients with bicuspid aortic stenosisYuheng Jia, Arif A Khokhar, Thomas Pilgrim, et al.
American Heart Journal|August 4, 2018
Impact of total ischemic time on manual thrombus aspiration benefit during primary percutaneous coronary interventionSarah Hugelshofer, Marco Roffi, Fabienne Witassek, et al.
Journal of the American Heart Association|December 29, 2023
Quantitative Flow Ratio to Predict Non-Target-Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary SyndromeSarah Bär, Raminta Kavaliauskaite, Tatsuhiko Otsuka, et al.
European Heart Journal|July 23, 2019
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysisGeorge C M Siontis, Pavel Overtchouk, Thomas J Cahill, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 3, 2021
Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE TrialJuan F Iglesias, Dik Heg, Marco Roffi, et al.
American Heart Journal|February 20, 2021
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trialsThomas Pilgrim, Martina Rothenbühler, George Cm Siontis, et al.
Pageof 136